A New Dawn for Early Cancer Diagnosis?

The University of Séchenav in Russia has unveiled Onkopró, a novel software system designed to enhance the early diagnosis of various cancers. This advancement arrives at a crucial time, as global cancer rates, particularly among younger demographics, are showing an alarming upward trend.

Onkopró leverages a simple blood test to identify individuals at risk of developing malignant neoplasms across six major cancer types: lung, kidney, breast, ovarian, prostate, and colorectal. The developers are optimistic about expanding the software’s capabilities to include additional cancer types in the future.

How Onkopró Works: A Deep Dive into the Technology

This innovative software employs a sophisticated algorithm based on 12 key indicators and three machine learning models. The system was trained using blood parameters from a cohort of 600 individuals, including 400 confirmed cancer patients. This data-driven approach allows Onkopró to identify subtle patterns indicative of early-stage cancer development.

The process is straightforward: patient blood analysis results, focusing on cancer-related indicators such as oncomarkers, inflammation markers, metabolic factors, and coagulation system data, are uploaded to the Onkopró platform. The system then calculates the individual’s risk of developing cancer by comparing their data against the established profiles of cancer patients. Individuals flagged as high-risk are recommended for further, more comprehensive examinations by their physicians.

Rigorous Testing and Promising Results

Before its official registration, Onkopró underwent extensive testing in a medical center and rigorous clinical trials. These trials were crucial in validating the software’s accuracy and reliability. Marina Sekacheva, the project director and head of the Institute of Personalized Oncology at the University, believes that Onkopró will become an invaluable tool for assessing cancer risk.

Doctors may make timely decisions to perform exhaustive exams to patients from risk groups, which, ultimately, will help detect more cases of cancer at an early stage.
Marina Sekacheva, director of the Institute of Personalized Oncology

The Shadow of Rising Cancer Incidence: A Global Concern

the introduction of Onkopró is particularly timely given the concerning rise in cancer diagnoses, especially among younger adults. Recent research underscores this alarming trend. As an example, a study published in Cancer Finding by researchers at the National Institutes of Health (NIH) revealed a important increase in the incidence of several cancer types among individuals under 50 between 2010 and 2019.

The NIH study, which analyzed 33 different cancer types, found that the incidence of 14 cancers increased in the under-50 age group. While some of these cancers also saw increased incidence in older populations (breast, colorectal, kidney, testicular, uterine, pancreatic, and certain lymphomas), others were primarily affecting younger individuals (melanoma, cervical, stomach, myeloma, and bone/joint cancers).

Specifically, breast, colorectal, kidney, and uterine cancers in women accounted for over 80% of the additional early-onset cancer cases in 2019 compared to the expected diagnoses based on 2010 rates. In absolute numbers, female breast cancer saw an estimated 4,800 additional cases in 2019, followed by colorectal cancer (2,100 cases), kidney cancer (1,800 cases), uterine cancer (1,200 cases), and pancreatic cancer (500 cases).

Unraveling the Causes: Potential Contributing Factors

Researchers are exploring various factors that may be contributing to this increase in early-onset cancers. Increased obesity rates are a prime suspect, potentially influencing the development of certain cancers. Changes in screening guidelines, advancements in imaging technologies, and heightened surveillance of high-risk individuals may also be leading to earlier diagnoses, thus contributing to the observed increase in incidence rates among younger age groups.

Looking Ahead: The Potential Impact of early Detection

While the reasons behind the rising cancer rates are still under inquiry, the development of tools like Onkopró offers a glimmer of hope. By enabling earlier detection, such technologies could significantly improve treatment outcomes and ultimately save lives. as cancer continues to pose a significant global health challenge, innovative solutions like Onkopró are essential in the fight against this devastating disease. The focus on early cancer detection and diagnosis remains a critical area for research and development.